Monday, 5 October 2020

Trending News: Medication Management Market 2020 | Global Updates | Demand and Growth

 Medication management is an approach to understand the purpose of the medications and its timely administration in the correct manner. Adherence to a medication regimen is vital especially for geriatrics and patients with multiple chronic conditions. Failing to comply with a medication regimen is often cited as a paramount reason why patients are readmitted in the hospital following discharge. 

Free Sample PDF Avvailable Here !! https://www.marketresearchfuture.com/sample_request/7187

In such scenarios, medication management services have been proving to be effective providing medication reconciliation, medication therapy management, patient/family education on medications and medication set-up simulations for the patient. Many home care providers have also started to make in-home medication management a core component of their operations.

For many aging populaces, relinquishing medication management services to a third party is one of the easier options. And it’s becoming a market differentiator among seniors looking for reliable, competent and service-minded companies to manage one of their most critical medical issues. 

Also, for the patients suffering from chronic illnesses who usually have to administer and monitor 10-12 medications per day, resorting to smart medication management systems which promote their wellbeing becomes useful. 

As a result, the uptake of medication management is growing which, in turn, is increasing the size of the global medication management market. Moreover, the recent trend of prescription medicine is escalating the market on the global platform. 

Considering the colossal growth, the market perceives currently; Market Research Future (MRFR), in its recently published study report asserts that the global medication management market will grow exponentially by 2023, registering approximately 13.4% CAGR throughout the forecast period (2018 – 2023).

Additional factors helping the market to boost further are the ever-increasing population, geriatric populaces, and increased occurrence of chronic diseases which are growing the need for the medication management solutions.

Advancements in IT technology and increasing uptake of healthcare IT for efficient management are expected to increase the size of the market. Furthermore, the rising government supports and the need for curtail healthcare costs without compromising the quality of care are some of the factors impacting the growth of the market, positively. 

On the other hand, factors such as high software implementation and service maintenance costs are impeding the growth of the market. Nevertheless, the advantages that medication management offers allowing the consolidation of all expenses which consequently saves the further cost of patient care is expected to act as a major tailwind supporting the growth of the market. 

 for care management solutions.  Moreover, the increasing healthcare expenditures are escalating the market on the global platform, increasing the need to curtail cost without compromising the quality of care.

 

Global Medication Management Market     – Segmentation

For ease of understanding, the MRFR analysis has been segmented into five key dynamics: -

By Systems                          Computerized Physician Order Entry Systems, Administration Software, Clinical Decision Support Systems, Inventory Management Systems, Automated Dispensing Systems, and Assurance Systems among others. 

By Services                          Point-of-Care Verification Services and Adverse Drug Effects (ADE) Surveillance Services among others. 

By Mode of Delivery        Web-based Solutions, On-premise Solutions, and Cloud-based Solutions among others.

By End-user                         : Hospitals and Pharmacies among others.

By Regions                          North America, Europe, Asia Pacific, and the Rest-of-the-World.

 

Medication Management Market – Regional Analysis

The North American region, heading with the presence of numerous key players is estimated to retain its dominance over the global medication management market. This region accounts for the best of the medical facilities around the world, and so is the higher rate of patients which along with the robust economy and high healthcare expenditure drive the medication management market in the region. 

Furthermore, the increasing number of polypharmacy, hospitals, and ambulatory centers alongside the well-developed technology drive the market growth in the region, meeting the higher demand of a vast patient population. 

The medication management market in the European region accounts for the next-largest market share, globally. Factors allowing the market to substantiate include the increasing demand for management software & platforms, strong government support, and availability of funds among others. Western European region backed by the presence of well-developed economies such as the U.K., Germany, and France holds a significant share in the regional market. Indeed, the resurging economy is playing a vital role in the growth of the market, making the high cost of medication affordable and increasing per capita income in this region. 

The Asia Pacific medication management market has emerged as a profitable market, globally. Factors such as the rapidly proliferating healthcare sector that is led by the improving economy, the increasing number of players, increasing government’s support and foreign investments, and vast technological advancements are impacting the regional market, positively. Additionally, the growing number of patients suffering from chronic diseases alongside the increasing per capita healthcare expenditure provide impetus to the growth of the market.

The Asia Pacific together accounts for over 41% of the global population, and most of the APAC countries are in the developing phase which leads to providing immense opportunities for the market players. Larger countries such as China and India backed by the densely populated area are considered as the biggest market for the Medication Management products in the region.

 

Global Medication Management Market – Competitive Analysis 

The medication management market appears fiercely competitive with the presence of several large and small players. The key strategies traced from the analysis of recent market developments include agreement & partnership, product launch, acquisition, and expansion.  International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional players to compete with them.

Major Players:

Key players leading the global medication management market include Mckesson Corporation, Allscripts Healthcare 0Electric Company, Medical Information Technology, Inc., Optum Inc., Omnicell, Inc., QuadraMed Affinity Corporation, and Siemens Ltd among others.

Industry, Innovation & Related News 

March 06, 2019 ---- BrightSpring Health Services (the US) a leading provider of comprehensive home and community-based health services announced its merge with the PharMerica (the US), a pharmacy powerhouse to position itself to lead the medication management, potentially.

BrightSpring hopes to effectively address medication needs while also providing caregiver services by providing its clients the right medications suiting their ailments in a timely and reliable manner and then helping to make sure they do so consistently. 

The merging deal will give BrightSpring a footprint with difficult-to-top proximity to the patients and clients it serves including behavioral health and specialty populations, along with older adults. KKR an affiliate of Walgreens Boots Alliance Inc. and a global investment firm had recently acquired BrightSpring (formerly ResCare) as part of the deal. 

Read Complete Report With Toc @ https://www.marketresearchfuture.com/reports/medication-management-market-7187

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

 

 

Analysis On Spirometry Market Size, trends, Research Report and Forecast

 

Spirometry Market Overview:

The global spirometry market is expecting to touch a valuation of USD 1,106.46 million by 2023, according to Market Research Future (MRFR).  The high prevalence of respiratory disorders is the major factor driving the market growth from 2018 to 2023 (forecast period). Rising cases of chronic obstructive pulmonary disorders (COPD), technological advances in respiratory care devices, and the expanding geriatric population are factors expected to spur market demand till 2023. As per a report by Asthma UK in 2016, nearly 1,410 people died from asthma.

Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/6539

Government initiatives to curtail smoking habits, focus on breathing diseases, rising levels of air pollution, and adoption of spirometers at homes are factors likely to augur market growth. Awareness of reimbursement policies among the public and clinicians are projected to drive patients towards taking these tests. But high costs of spirometers can act as a deterrent against market growth.

Spirometry Market Segmentation:

The spirometry market forecast can be segmented by product, technology, application, and end-user.

By product, the market is segmented into table-top spirometry, hand-held spirometry, and desktop (PC) spirometry. The table-top spirometry segment accounted for 49.9% market share in 2017, followed by hand-held (31%), and desktop (19.1%). This can be attributed to adoption of spirometers in hospitals and clinics. But the desktop segment is touted to register the highest CAGR of 10.58% during the forecast period owing to its rapid diagnosis rate and increasing use of computer-based applications.

By technology, the market covers flow measurement spirometry, volume spirometry, and peak flow meters (PFM). The flow measurement spirometry segment accounted for 50.3% share in 2017. This can be attributed to its lightweight nature and compact size. Its functionality based on the familiar table-top spirometer technology and lack of frequent calibration make it popular among clinicians. But the PFM technology can register 10.58% CAGR over the forecast period to reach USD 149.76 million by 2023.

Major applications of the spirometry market include diagnostic and treatment monitoring. The diagnostic segment is further sub-segmented into asthma, interstitial pulmonary fibrosis, and COPD. The diagnostic segment accounted for 68.93% share of the market in 2017, spurred by the prevalence of breathing diseases such as asthma. But the treatment monitoring segment can exhibit the highest CAGR during the review period to reach a valuation of USD 353 million by 2023. Its valuation in 2018 was suggested to be USD 214.12 million.

Key market end-users include hospitals & clinics, research & academic institutes, diagnostic centers, and home care. The home care segment is projected to enjoy a 9.90% CAGR to reach a valuation of USD 71.14 million by 2023 from USD 44.38 million in 2018.

Spirometry Market Regional Analysis:

The spirometry market covers the latest trends and opportunities across Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas accounted for 39.74% share in the global market in 2017, followed by Europe and APAC. This can be attributed to economies such as the U.S. which are the earliest adopters of latest technologies coupled with the large patient pool suffering from respiratory disorders. The region is likely to enjoy a 10.25% CAGR over the forecast period.

The Europe spirometry market is expected to enjoy a CAGR similar to the Americas market over the forecast period to touch a valuation of USD 322.33 million by 2023. This can be credited to rising number of asthma cases and ballooned healthcare expenditure of nations such as Germany and France.

The MEA region can experience a respectable CAGR during the review period owing to improvements of healthcare infrastructure and enhanced healthcare budgets of Kuwait, Qatar, and Dubai.

The APAC region is expected to exhibit a 10.94% CAGR over the forecast period owing to high cases of chronic diseases, awareness of respiratory devices, and increased healthcare budgets of developed nations in the region. The growing geriatric populace in China and Japan can contribute to regional market revenue till 2023.

Spirometry Market Competitive Dashboard:

Key players in the spirometry market include Smiths Medical Inc. (U.S.), Vitalograph (U.K.), MGC Diagnostics Corporation (U.S.), Hill-Rom Holdings, Inc. (U.S.), Schiller AG (Switzerland), COSMED srl (Italy), Midmark Corporation (U.S.), NDD Medical Technologies, Inc. (U.S.), Carefusion Corporation (U.S.), Nihon Kohden Corporation (Germany), and Koninklijke Philips N.V. (The Netherlands).

Access Report @ https://www.marketresearchfuture.com/reports/spirometry-market-6539

 

Covid19 Impact on Healthcare Industry Report

Gastroscopes Market research Report - Global Forecast till 2023: https://www.marketresearchfuture.com/reports/acute-myeloid-leukemia-treatment-market-3223

Advanced Baby Monitors Market research Report - Global Forecast till 2025: https://www.marketresearchfuture.com/reports/advanced-baby-monitors-market-6525

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Updates 2020: Neurovascular Medical Devices Market- Report, Trends and Technology Demand

 Neurovascular devices are devices used in the treatment of neurovascular diseases such as brain aneurysm, arteriovenous malformations, and others. The global neurovascular devices market report by Market Research Future (MRFR) contains useful insights and in-depth analysis of the pivotal market variables affecting the industry. It contains estimations for the period of 2018 to 2023 (forecast period) and the impact of the COVID-19 virus on the market.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5544

Market Scope

The global neurovascular Medical devices market is set to touch a value of USD 3,177.76 million by 2023. It is expected to register a CAGR of 8.8% over the forecast period. Development of products, approval by regulatory bodies, and demand for minimally invasive procedures are major factors driving market growth. The large healthcare expenditure of nations is an instance of the large potential for the market. The NHS, a government agency of the U.K. government, had spent close to USD 6.6 billion for the period of 2012-2013. The outbreak of the COVID-19 pandemic has led to efforts being put into the manufacture of ventilators and other equipment and putting a halt in production of neurovascular devices.

But high procedural costs and lack of skilled personnel can hamper the market growth.

Segmentation

The global neurovascular devices market is segmented on the basis of product, therapeutic application, and end-user.

On the basis of the product, the market is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty and stenting systems, neurothrombectomy devices, and support device. The aneurysm coiling & embolization devices segment is sub-segmented into liquid embolic, embolic coils, and flow diversion devices. The embolic coils segment is further segmented into detachable coils, and pushable coils. Meanwhile, the neurothrombectomy devices segment is sub-segmented into retrieval systems and suction and aspiration devices. The support device segment is sub-segmented into microcatheters and microguidewires. Lastly, the cerebral balloon angioplasty and stenting systems segment is sub-segmented into carotid artery stents and embolic protection systems. The embolic protection systems segmented is further divided into balloon occlusion devices and distal filter devices.

On the basis of the therapeutic application, the market is divided into hemorrhagic stroke and ischemic strokes.

On the basis of the end-users, the market is segmented into hospitals & clinics, and ambulatory surgical units.

Regional Analysis

The Americas can dominate the global neurovascular devices market owing to increasing prevalence of neurovascular diseases like arteriovenous malformations (AVMs), brain aneurysm, and others. According to a study published in the Methodist DeBakey Cardiovascular Journal in 2014, about one million strokes occurred annually in the U.S. with 10% to 15% with the cause accounted to intracranial atherosclerotic disease. The inflated healthcare expenditure and presence of key players within the region can widen the scope of the market in the region.

Europe is the second-largest neurovascular devices market. This can be attributed to the presence of a well-developed healthcare sector and increasing prevalence of neurovascular diseases. According to the Neurological Alliance in 2014, neurological cases in England had reached 12.5 million. This is expected to fuel the demand for neurovascular devices.

APAC follows Europe and is touted to exhibit a robust CAGR over the forecast period. The large patient pool, medical tourism in India and China, and massive demand for minimally invasive surgeries are prime factors driving the regional market growth. On the other hand, the MEA has the least share of the global neurovascular devices market due to the presence of poor economy, especially in the Africa region.

Competition Outlook

  1. L. Gore & Associates, Inc., Blockade Medical, LLC., MicroPort Scientific Corporation, Rapid Medical, Johnson & Johnson Services, Inc., Gynesonics, Medtronic, Secant Group, LLC, Medikit Co., Ltd., Penumbra, Inc., Sensome, Neuravi, Merit Medical Systems, Inc., Evasc, Delaware Corporation, TERUMO CORPORATION, Abbott, OxfordEndovascular, and Stryker are key players of the global neurovascular devices market.

Read More !! https://www.marketresearchfuture.com/reports/neurovascular-devices-market-5544

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

News Updates: Diagnostic Imaging Services Market Size, Share, global Analysis and Demand

 Diagnostic Imaging Services Market Research Report: by Procedure (Computed Tomography, MRI, X-ray), by Application (Neurology, Oncology, Cardiology), By Service Provider (Diagnostic centres) - Global Forecast Till 2023

Market Highlights

The Global diagnostic imaging market is projected to grow at a CAGR of 8.2% over the forecast period. In recent years, diagnostic imaging services improved their efficiency and accuracy for the of various acute and chronic diseases including cardiovascular diseases and cancer. The increasing prevalence of geriatric population and subsequent growth in the incidence of cardiac, and neurological diseases including cancer, growing government funding’s for development of medical diagnostics field, and the on-going technological advancements in imaging services are some factors that are anticipated to drive the market growth during the assessment period.  Additionally, increasing demand for diagnostic imaging devices and development expenditure by the government as well as private sector is likely to contribute to the market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, high cost of diagnostic imaging devices and unfavorable reimbursement policies may hamper the market growth during the assessment period.

Key Players

Some of the prominent players in the global diagnostic imaging services market are Center for Diagnostic Imaging (CDI), Medquest Associates Inc./Novant Health, Simonmed/Dignity Health, Touchstone Imaging, Alliance Medical, Medica Group, Sonic Healthcare, Global Diagnostics, Consensys Imaging Service, Inc., Progressive Radiology, Concord Medical Services Holdings Limited, Alliance Healthcare Services, InHealth Group and others. 

Get Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7186

Regional Analysis

On regional basis, the Americas is anticipated to dominate the global diagnostic imaging services market owing to the growing clinical R&D budgets by both government as well as public and private organizations in diagnostic imaging modalities and increasing adoption of advanced technologies in the region.  Additionally, rising prevalence of geriatric population along with various chronic diseases is contributing the growth of this market. According to a report by Population Reference Bureau, the number of older population (aged 65 and above) will rise to nearly 24% from 15% by 2060. Europe is expected to hold the second largest position in the global diagnostic imaging services market owing to the presence of strong academic & research base and availability of funding for research in the European countries. Moreover, rising healthcare expenditure and awareness among people for detection of diseases is boosting the market in this region. The Asia-Pacific region is anticipated to be fastest growing region is due to rising demand for imaging devices, good quality healthcare infrastructure and incidence of major key players for growth and development in this region. The Middle East & Africa has the least share of the global diagnostic imaging services market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.

 Segmentation

The Global diagnostic imaging services market has been segmented into procedure, application, and service provider.

By procedure, the market has been segmented into X-ray, Computed Tomography, Ultrasound, MRI (Magnetic Resonance Imaging), Nuclear Imaging, Radiography and others. The procedure segment is estimated to hold major market share in the global diagnostic imaging services market due to the rising R&D activities in the medical diagnostics field.

On the basis of application, the global diagnostic imaging services market has been segmented into Neurology, Cardiology, Oncology, Musculoskeletal and others.

The Global diagnostic imaging services market, by service provider, has been segmented into Clinics & Hospitals, Diagnostic centers, Research laboratories and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/diagnostic-imaging-services-market-7186

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Cruciate Ligament Repair Procedures Market to Exhibit a CAGR of 6.4% During 2020-2023

 Market Highlights

The cruciate ligament treatment includes numerous surgical techniques that involve reconstruction and replacement of the knee and related ligaments. The upsurge in obese population is considered as a chief factor emphasizing the growth of this market. Obesity in the aging population has been reported to directly increase the risk of degenerative bone disorders, such as osteoporosis and osteoarthritis, additionally resulting in target injury and fracture owing to the extra pressure exerted on joints. Later, increasing number of people who have osteoporosis is expected to generate demand for the market.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6080   

However, the lack of availability of skilled professionals and the high cost of treatment procedures may hinder the growth of the market during the forecast period.

Many prominent players in the market have incorporated into acquisitions, mergers, and continuous launches of quality systems to hold the market position. The firms are focusing on mergers and acquisitions to enhance their product portfolio. For instance, the acquisition of Cayenne Medical by Zimmer Biomet was involved in reconstruction solutions and advanced soft tissue repair for knee, shoulder, and extremities. Besides, companies are involving into geographic expansions to cater to the untargeted population for tissue repair and surgeries.

Regional Analysis

The global Cruciate Ligament Repair Procedures Market consists of four regions, namely, Americas, Europe, Asia Pacific, and the Middle East and Africa.

The American region holds the major share of the global cruciate ligament diagnosis and treatment market, owing to the existing well-established healthcare system, increasing prevalence of degenerative bone disorder cases, and technological advancements. Sports such as soccer, football, and skiing have been reported to be high-risk sports that can cause injury to the ACL when compared to other sports activities. For instance, due to increasing occurrences of ACL injuries, nearly 100,000 ACL reconstructions are performed each year as per a report published by PubMed.

Europe holds the second position in the global cruciate ligament diagnosis and treatment market. It is expected that the government support towards research and development expenditure and rising prevalence of chronic bone diseases are likely to drive the European cruciate ligament diagnosis and treatment market.

The Asia Pacific cruciate ligament diagnosis and treatment market consist of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia Pacific. Japan is the largest market for cruciate ligament diagnosis and treatment due to an increase in the prevalence of cancer and demand for cruciate ligament diagnosis and treatment techniques. In China, factors responsible for the market growth are rising geriatric population with osteoporosis diseases and availability of low-cost diagnostic and treatment options.  

The Middle East and Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.

Access Report @ https://www.marketresearchfuture.com/reports/cruciate-ligament-diagnosis-treatment-6080

Segmentation

The global cruciate ligament diagnosis and treatment market is segmented on the basis of type, injury type, product, diagnosis, treatment, and end-user.

Based on type, the global cruciate ligament diagnosis and treatment market is classified as Posterior Cruciate Ligament (PCL) and Anterior Cruciate Ligament (ACL).

The segments for injury type for the global cruciate ligament diagnosis and treatment market are classified as grade I, grade II, and grade III.

On the basis of product, the global cruciate ligament diagnosis and treatment market is classified as cemented implants, cement-less implants, partial implants, and revision implants.

Based on indication, the global cruciate ligament diagnosis and treatment market is classified as osteoarthritis, rheumatoid arthritis, trauma, and others.

The diagnosis segment for the global cruciate ligament diagnosis and treatment market is classified as imaging and others. The imaging segment is further classified as abdominal x-ray, Magnetic Resonance Imaging (MRI), ultrasound, laparoscopy, angiography, and others.

Based on treatment, the global cruciate ligament diagnosis and treatment market is classified as surgery, therapies, devices, and others. Surgery can be further sub-divided into arthroscopy, Anterior Cruciate Ligament (ACL) reconstruction, and others. The therapies include rehabilitation and physical therapies. The devices include elastic bandages and others.

On the basis of end-user, the global cruciate ligament diagnosis and treatment market is classified as hospitals, orthopedic clinics, Ambulatory Surgical Center (ASC), and others.

Global Cruciate Ligament Diagnosis & Treatment Market, by type

  • Posterior Cruciate Ligament (PCL)
  • Anterior Cruciate Ligament (ACL)

Global Cruciate Ligament Diagnosis & Treatment Market, by Injury type

  • Grade I
  • Grade II
  • Grade III.

Global Cruciate Ligament Diagnosis & Treatment Market, by Indication

  • Osteoarthritis
  • Rheumatoid arthritis
  • Trauma

Global Cruciate Ligament Diagnosis & Treatment Market, by Product

  • Cemented implants
  • Cement-less implants
  • Partial implants
  • Revision implants.

Global Cruciate Ligament Diagnosis & Treatment Market, by Diagnosis

  • Imaging
  • Magnetic Resonance Imaging (MRI)’
  • Ultrasound
  • Laparoscopy
  • Others

Global Cruciate Ligament Diagnosis & Treatment Market, by Treatment

  • Surgery
  • Arthroscopy
  • Anterior Cruciate Ligament (ACL) reconstruction
  • Others
  • Therapies
  • Rehabilitation
  • Physical Therapies
  • Devices
  • Elastic Bandages
  • Others

Global Cruciate Ligament Diagnosis & Treatment Market, by End-user

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgical Center (ASC)

Global Cruciate Ligament Diagnosis & Treatment Market, by Region

  • Americas
  • North America
  • U.S.
  • Canada
  • South America
  • Europe
  • Western Europe
  • Germany
  • France
  • Italy
  • Spain
  • U.K.
  • Rest of Western Europe
  • Eastern Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Republic of Korea
  • Rest of Asia Pacific
  • The Middle East & Africa
  • Middle East
  • Africa

Company Profiles    

  • Stryker Corporation
  • Arthrex, Inc.
  • Zimmer Biomet
  • DePuy Synthes, Inc.
  • CONMED Corporation
  • Smith & Nephew plc.
  • DJO Global Inc.
  • Breg, Inc.
  • Bauerfeind AG

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.


Sunday, 4 October 2020

 Artificial Intelligence (AI) in Drug Discovery Market Overview

AI drug discovery has proved itself as a vital part of the drugs industry. This technology is used for regulating drug innovation & progress costs and in decreasing the processing time. Fast adoption and other features will help the global AI in the drug discovery market to touch a 41% annual growth rate. AI method uses different algorithms for improving the drug designs, their molecular structures and classification of various forms of drugs. All of the above features are adding to the tally of the market and giving it a considerable push to reach new levels of success.

Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/9393

AI in drug discovery has enlightened the workflow of medical facilities, and on the same page has helped in boosting care facilities. Extensive medical facilities have always tried to opt for better services and latest technologies with minimum space for mistakes. This technology has fastened the drug construction procedures for cases which need specialised medicinal attention, decreases failure risks and also the cost of research & development procedures. All these major features have pushed the authorities to adopt AI technology and have increased the AI in the drug discovery market.

In the absence of AI technology, any new drug development procedures can take years for development and substantial money. Apart from all these factors, AI is still a faraway story for most economies as it is costly, limited awareness and lack of skilled professional workers. These points are a major setback for the growth of the industry.

Market Segments of the Artificial Intelligence (AI) in Drug Discovery Market

The global market for AI in drug discovery is segmented into three factors:

Product type: There are three types of products, namely software, hardware and services.

Technology-based: Technologies like machine learning, deep learning, natural language processing and querying method are some examples of technology.

Application-based: AI technology is used in candidate screening, preclinical testing, target identification and others.

End-Users: Contract research organisations (CROs), pharma and biotech industries and government research facilities are some of the end-users.

Artificial Intelligence (AI) in Drug Discovery Market Regional Overview

America, Europe, Asia Pacific and The Middle East & Africa are the four markets observed for the AI in drugs discovery market size.

The American region is the current market leader with the US and Canada as the major shareholding markets. Demand for new technologies, the presence of sound AI developers and increased investments in the direction of research & development are the major factors driving the market in this region. This region will maintain its position until the projected period.

The European region is the second-largest AI market. With the increasing demand for faster results and accuracy are helping the global AI in the drug discovery market grow in this region. Authorities and industries are hiring and collaborating with AI experts for easy attainment of such methods.

Asia Pacific region is in third place but will pop out as the fastest growing market in future perspective. There are continuous efforts to make this technology a common practice, and for that, companies are collaborating for better and reliable results.

The Middle East & African region is the smallest industry due to low economic developments and deliberate efforts towards creating a strong medical sector.

Recent Industry News

As a costly technology, efforts are required to develop more adaptable technologies which become suitable for all and will expand this industries base. Asia Pacific region is making substantial efforts in adopting and developing in technologies, making it the fastest-growing market on a global scale. 

Key Players

  • Microsoft Corporation
  • IBM Corporation
  • Google (A Subsidiary of Alphabet Inc.)
  • Atomwise, Inc.
  • Deep Genomics
  • Cloud Pharmaceuticals, Inc.
  • Insilico Medicine
  • BenevolentAI
  • Exscientia
  • Cyclica
  • Bioage
  • Numerate
  • Numedii, Inc.
  • Envisagenics
  • Twoxar, Incorporated
  • Owkin, Inc.
  • Xtalpi, Inc.
  • Verge Genomics
  • Berg LLC

 

Read Complete Report With Toc @ https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com 
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

Friday, 2 October 2020

Lab-on-a-Chip Market- Global Analysis, Report and Trends

 Lab-on-a-Chip Market Overview:

The global Lab-on-a-Chip Market to experience a staggering growth with a CAGR of 10% during the forecast period (2018-2023), in an extensive report reveals Market Research Future (MRFR). Lab-on-a-chip brings in diverse laboratory processes on a minimally sized integrated circuit and eases the sample handling process and within a flicker delivers results with excellent efficiency. 

Free PDF @ https://www.marketresearchfuture.com/sample_request/6215

Drivers and Restraints:

Quick sampling and precise results, within a very short span of time, can solve problems such as drug wastage, and drug resistance. This also enables patients to have a timely diagnosis and ensures enough time to start the necessary medical procedures. LoC offers optimization of the process and gains traction in the process enough to enjoy accolades from the various corners of the medical sector. 

LoC is experiencing popularity in diagnosing various infections and chronic diseases along with multiple tests of diverse disciplines such as Botany. Factors that are airing the demand for LoC are its portability, automated sample handling, and easy configurability. Also, the microfluidic LoC has the potential to revolutionize the biomedical field.

However, a few factors can impede the market growth such as high initial cost and lack of awareness in countries with people mostly belonging to the middle-income group. But LoC is slowly becoming an integral part of the diagnosing procedure which can marshal the market to overcome such irritants.

Industry Trends:

A Scotland based company uFraction8 Ltd. has recently come up with a microfluidic-based filtration system which is an essential part in remodeling the LoCs. Other innovations are also startling and can revolutionize the segment by taking the practice some light years ahead. Researchers from the Brigham Young University have now developed a technology that can 3D print LoC.

Segmentation:

The global Lab on a chip market can be segmented by product, technology, application, and end-user. 

Product-wise, the market includes instruments, reagents & consumables, software, and others. Researchers from Biozentrum of the University of Basel and Max Planck Institute in Dresden have set up a LoC along with automatic analysis software that can study single cell responses. 

Based on application, the market comprises genomics, proteomics, the point of care diagnostics, drug discovery and others. LoC has revamped genomic field of study by taking down the time of detection by a considerable margin. Researchers from Griffith University’s Queensland Micro and Nanotechnology Centre have discovered new ways to screen drugs by using LoC that would reduce the drug testing time considerably.

By end-user, the market consists, hospitals and clinics, biotechnology and pharmaceutical companies, forensic laboratories, diagnostics centers, and academic & research institutes.

Regional Analysis:

Region-wise the market covers the Americas, Europe, the Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas are leading the market owing to their huge expenditure in molecular biology and genetic engineering to counter infectious diseases. Genomic and proteomic researches are also spurring the demand for such technology and accordingly LoC is getting significant funds from various organizations. Its precision in diagnosis and ability to handle multiple samples simultaneously are also proving effective for chronic disease treatment. 

Europe is the second largest market due to its flourishing medical device market and favorable government initiatives that are funding researches. Growing per-capita income of individuals is also proving to be a significant factor.

The APAC is expected to be the fastest growing region as it has a huge patient pool suffering from diverse kind of chronic and infectious diseases. Also, the region is adopting the latest technologies. Governments are promoting favorable market conditions due to which a lot of international players are setting up their factories and laboratories in this region.

The MEA is expected to register a meager market share as the region lacks awareness and proper facilities. The United Arab Emirates holds the largest market share as it has adequate healthcare facilities and the economic status of the citizens. 

 

Market Dashboard:

 

The competitive market is banking much on research & developments and merger & acquisitions. For instance, Becton-Dickinson and Company have recently acquired C. R. Bard to expand their portfolio. Agilent Technologies has also acquired Advanced Analytical Technologies, Inc. in a bid to explore much of electrophoresis space. 

 

Key companies that are playing contributing the most in the market are Becton-Dickinson and Company, Agilent Technologies, Inc., Danaher Corporation, Bio-Rad Laboratories, Abbott Laboratories, Hoffmann-La Roche AG, PerkinElmer, Inc., IDEX Corporation, Thermo Fisher Scientific, Inc., Cepheid Inc., Biacore AB, and others.

 

Read More About Lab on a Chip Market @https://www.marketresearchfuture.com/reports/lab-on-a-chip-device-market-6215

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:                                    

Akash Anand                                                                        

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com